NCT03122847View on ClinicalTrials.gov

Glucocorticoids and Bone in Graves' Ophthalmopathy

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

July 14, 2022

Study Completion Date

February 1, 2024

Conditions
Graves Ophthalmopathy
Interventions
DRUG

Methylprednisolone

Intravenous methylprednisolone

Trial Locations (2)

8000

Aarhus University Hospital, Aarhus C

5000C

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Torben Harsløf

OTHER

NCT03122847 - Glucocorticoids and Bone in Graves' Ophthalmopathy | Biotech Hunter | Biotech Hunter